Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million
26/02/2026 01:34
Feb 26 (Reuters) - Microba Life Sciences Ltd MAP.AX: LOSS FOR HALF-YEAR ATTRIBUTABLE A$10.6 MILLION HY REVENUES FROM ORDINARY ACTIVITIES A$7.3 MILLION Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement